These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17571459)

  • 21. The importance of the spleen in malaria.
    Engwerda CR; Beattie L; Amante FH
    Trends Parasitol; 2005 Feb; 21(2):75-80. PubMed ID: 15664530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of a multivalent DNA vaccine for malaria.
    Hedstrom RC; Doolan DL; Wang R; Gardner MJ; Kumar A; Sedegah M; Gramzinski RA; Sacci JB; Charoenvit Y; Weiss WR; Margalith M; Norman JA; Hobart P; Hoffman SL
    Springer Semin Immunopathol; 1997; 19(2):147-59. PubMed ID: 9406343
    [No Abstract]   [Full Text] [Related]  

  • 23. The immunological challenge to developing a vaccine to the blood stages of malaria parasites.
    Good MF; Stanisic D; Xu H; Elliott S; Wykes M
    Immunol Rev; 2004 Oct; 201():254-67. PubMed ID: 15361246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
    Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
    Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular strategy for parasitism and vaccine development of falciparum malaria].
    Horii T
    Tanpakushitsu Kakusan Koso; 2001 Dec; 46(15):2154-62. PubMed ID: 11762075
    [No Abstract]   [Full Text] [Related]  

  • 26. Progress in the development of recombinant and synthetic blood-stage malaria vaccines.
    Mahanty S; Saul A; Miller LH
    J Exp Biol; 2003 Nov; 206(Pt 21):3781-8. PubMed ID: 14506213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing a malaria vaccine.
    Targett GA
    J Clin Pathol; 1997 Jul; 50(7):535-6. PubMed ID: 9306927
    [No Abstract]   [Full Text] [Related]  

  • 28. [NANP]19-5.1. A malaria vaccine field trial in Nigerian children.
    Reber-Liske R; Salako LA; Matile H; Sowunmi A; Stürchler D
    Trop Geogr Med; 1995; 47(2):61-3. PubMed ID: 8592764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium falciparum malaria vaccines in development.
    Vekemans J; Ballou WR
    Expert Rev Vaccines; 2008 Mar; 7(2):223-40. PubMed ID: 18324891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [P. falciparum antigens at different stages of a parasitic cycle].
    Popov AF; Chirkov VP
    Med Parazitol (Mosk); 2005; (2):23-6. PubMed ID: 15984613
    [No Abstract]   [Full Text] [Related]  

  • 31. Meeting report: the molecular background of severe and complicated malaria.
    Winter G; Chen Q; Wahlgren M
    Mol Biochem Parasitol; 2004 Mar; 134(1):37-41. PubMed ID: 14747141
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36.
    Horii T; Shirai H; Jie L; Ishii KJ; Palacpac NQ; Tougan T; Hato M; Ohta N; Bobogare A; Arakaki N; Matsumoto Y; Namazue J; Ishikawa T; Ueda S; Takahashi M
    Parasitol Int; 2010 Sep; 59(3):380-6. PubMed ID: 20493274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.
    Walther M
    Expert Rev Vaccines; 2006 Feb; 5(1):81-93. PubMed ID: 16451110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A malaria vaccine based on a sporozoite antigen.
    Nussenzweig RS; Zavala F
    N Engl J Med; 1997 Jan; 336(2):128-30. PubMed ID: 8988893
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.
    Zhang D; Pan W
    Infect Immun; 2005 Oct; 73(10):6530-6. PubMed ID: 16177327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research toward vaccines against malaria.
    Miller LH; Hoffman SL
    Nat Med; 1998 May; 4(5 Suppl):520-4. PubMed ID: 9585203
    [No Abstract]   [Full Text] [Related]  

  • 37. RTS,S/AS02A for malaria.
    Bojang KA
    Expert Rev Vaccines; 2006 Oct; 5(5):611-5. PubMed ID: 17181435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
    Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
    Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune effector mechanisms in malaria.
    Marsh K; Kinyanjui S
    Parasite Immunol; 2006; 28(1-2):51-60. PubMed ID: 16438676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
    Sutherland CJ
    Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.